Large-scale testing (Phase 3)Study completedNCT00063141
What this trial is testing
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,302